Publications
Detailed Information
Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jae-Young | - |
dc.contributor.author | Termsarasab, Ubonvan | - |
dc.contributor.author | Park, Ju-Hwan | - |
dc.contributor.author | Lee, Song Yi | - |
dc.contributor.author | Ko, Seung-Hak | - |
dc.contributor.author | Shim, Jae-Seong | - |
dc.contributor.author | Chung, Suk-Jae | - |
dc.contributor.author | Cho, Hyun-Jong | - |
dc.contributor.author | Kim, Dae-Duk | - |
dc.date.accessioned | 2024-04-26T00:26:43Z | - |
dc.date.available | 2024-04-26T00:26:43Z | - |
dc.date.created | 2017-11-15 | - |
dc.date.issued | 2016-08 | - |
dc.identifier.citation | Journal of Controlled Release, Vol.236, pp.38-46 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://hdl.handle.net/10371/199510 | - |
dc.description.abstract | Dual CD44 and folate receptor targetable nanoparticles (NPs) based on hyaluronic acid-ceramide-folic acid (HACE-FA) were fabricated for improving tumor targetability. HACE-FA was synthesized via esterification between the carboxylic group of FA and hydroxyl group of HA. Doxorubicin (DOX)-loaded HACE-FA NPs, with a mean diameter of 120-130 nm, narrow size distribution, and negative zeta potential, were prepared. The drug release from HACE-FA NPs were significantly increased in acidic pH (pH 5.5) compared with physiological pH (7.4) (p < 0.05). The cellular accumulation of the drug in HACE-FA NPs group was higher than that of HACE NPs group in SKOV-3 cells (human ovarian cancer cells; CD44 and folate receptor (FR)-positive cells). Dual targetability of HACE-FA NPs, compared to HACE NPs, was also verified in the SKOV-3 tumor-xenografted mouse model by near-infrared fluorescence (NIRF) imaging. Twenty-four hours after injection, HACE-FA NPs were accumulated mainly in tumor regions and their fluorescence intensity was 4.82-fold higher than that of HACE NPs (p < 0.05). These findings suggest successful application of HACE-FA NPs for the accurate delivery of anticancer drugs to ovarian cancer. (C) 2016 Elsevier B.V. All rights reserved. | - |
dc.language | 영어 | - |
dc.publisher | Elsevier BV | - |
dc.title | Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jconrel.2016.06.021 | - |
dc.citation.journaltitle | Journal of Controlled Release | - |
dc.identifier.wosid | 000380246400005 | - |
dc.identifier.scopusid | 2-s2.0-84975894176 | - |
dc.citation.endpage | 46 | - |
dc.citation.startpage | 38 | - |
dc.citation.volume | 236 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Lee, Jae-Young | - |
dc.contributor.affiliatedAuthor | Chung, Suk-Jae | - |
dc.contributor.affiliatedAuthor | Kim, Dae-Duk | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | SELF-ASSEMBLED NANOPARTICLES | - |
dc.subject.keywordPlus | HYALURONIC-ACID | - |
dc.subject.keywordPlus | BLOCK-COPOLYMERS | - |
dc.subject.keywordPlus | OVARIAN-CANCER | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | THERAPEUTICS | - |
dc.subject.keywordPlus | NANOCARRIERS | - |
dc.subject.keywordPlus | LIPOSOMES | - |
dc.subject.keywordPlus | MICELLES | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | CD44 receptor | - |
dc.subject.keywordAuthor | Dual targeting | - |
dc.subject.keywordAuthor | Folate receptor | - |
dc.subject.keywordAuthor | Hyaluronic acid-ceramide-folic acid | - |
dc.subject.keywordAuthor | Nanoparticles | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.